pharmaceuticals
Show me the money
PBS a huge area of savings compared to other government-administered services including medical and hospital costs Costs of essential goods and services are climbing at twice the rate of inflation, …
‘Most widely misused’: benzos, opioid analgesics
A new report tabled in Victorian Parliament has highlighted misuse of pharmaceuticals as the leading cause of drug-induced deaths in Australia The Victorian Parliament’s Law Reform, Road and Community Safety …
Pharma’s footprint
Unwanted, expired and improperly disposed of medicines pose a serious threat to people, animals and the environment. How can pharmacists play an active role in reducing the impacts? How active …
Report: 80% of Chinese clinical drug trial results “fabricated”
A government review of trials for new pharmaceutical drugs has revealed large-scale fraud in the industry According to Chinese publication Economic Information Daily, the country’s State Food and Drug Administration …
Potential new drug to treat severe, uncontrolled asthma
Trial results suggest treatment could be used as an add-on therapy for severely asthmatic patients Two phase III, double-blind, randomised controlled trials including more than 2500 participants looked at the safety …
GSK tops Fortune list of world-changing companies
The pharmaceutical giant was ranked first for its “unmatched record for balancing scientific progress, social impact and the profit motive” Fortune magazine and a panel of experts recently named GlaxoSmithKline the …
Pfizer and Allergan deal off
Pfizer and Allergan’s merger has been scuppered by new US legislation, news agency Reuters is reporting. Pfizer has decided to terminate the agreement to acquire Allergan, a $160 billion agreement …
‘For-benefit’ pharma company launched
This week’s launch of Australia’s first ‘for-benefit’ pharmaceutical company is ushering in a new era of social enterprise that’s set to challenge the conventional for-profit pharma model, say stakeholders. For …
30% decline highlights pharma struggle: Medicines Australia
Australian medicines exports have declined by 30% in one year, and Medicines Australia says this highlights the enormous challenges facing the local industry as they struggle to remain competitive in …